Validation of the Rhinitis Control Scoring System (RCSS)

Laval University

Status: Suspended

Conditions: Asthma; Rhinitis

Treatments: Drug: Medication Mometasone furoate and desloratadine

Study type: Interventional

Funder types: Other

Identifiers

NCT00967967

CER 20389

Details and patient eligibility

About

Many patients suffering from allergic rhinitis do not recognize or perceive their symptoms. Instruments have been developed to assess quality of life in rhinitis, asthma or both, but there is a need to develop validated tools or methods to assess rhinitis control among rhinitis and/or asthmatic patients. The aim of this study is to assess the discriminative and evaluative properties of the RCSS in asthmatic patients with allergic rhinitis.

Full description

Allergic asthmatic subjects showing seasonal rhinitis symptoms will be recruited. The discriminative (internal consistency, cross sectional construct validity and reliability) and evaluative (responsiveness and longitudinal construct validity) properties of the RCSS will be evaluated as well as the relationship between rhinitis control and asthma control. RCSS will be completed at various time points during the seasonal allergic period.

Enrollment: 50 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• asthma
• seasonal allergic rhinitis

Exclusion criteria

• smoking
• nasal polyposis

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Mometasone furoate and desloratadine

Other group

Description:

Mometasone and desloratadine treatment

Treatment:

Drug: Medication Mometasone furoate and desloratadine